Humira (International)
In the US, Humira (adalimumab systemic) is a member of the following drug classes: antirheumatics, TNF alfa inhibitors and is used to treat Ankylosing Spondylitis, Crohn's Disease, Crohn's Disease - Active, Crohn's Disease - Maintenance, Hidradenitis Suppurativa, Plaque Psoriasis, Polyarticular Juvenile Idiopathic Arthritis, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis and Uveitis.
US matches:
- Humira
- Humira Pen
- Humira Pre-filled Syringe
- Humira Pediatric Crohns Start
- Humira Pen-CD/UC/HS Starter
- Humira Pen-Ps/UV Starter
Ingredient matches for Humira
Adalimumab
Adalimumab is reported as an ingredient of Humira in the following countries:
- Argentina
- Australia
- Belgium
- Bosnia & Herzegowina
- Brazil
- Canada
- Chile
- China
- Colombia
- Croatia (Hrvatska)
- Cyprus
- Czech Republic
- Denmark
- Ecuador
- Egypt
- Estonia
- Finland
- France
- Germany
- Greece
- Hong Kong
- Iceland
- Ireland
- Italy
- Japan
- Latvia
- Lebanon
- Lithuania
- Macedonia
- Mexico
- New Zealand
- Norway
- Oman
- Paraguay
- Peru
- Poland
- Portugal
- Romania
- Serbia
- Singapore
- Slovakia
- Slovenia
- South Africa
- South Korea
- Spain
- Sweden
- Taiwan
- Tunisia
- Turkey
- United Kingdom
- United States
- Uruguay
- Venezuela
- Vietnam
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
